FDA.reportPublic FDA data

atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML [Duodote]

RxCUI
1666956
RxNorm name
atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML [Duodote]
Term type
SBDC
Status
Active
Updated
2026-10-20 20:52:05

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102015
Active start
102015
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
0.778 MG / 1 MLatropine
222 MG / 1 MLpralidoxime

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
atropine1223
pralidoxime34345

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRatropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML [Duodote]1NAMES
RxNorm Nameatropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML [Duodote]1NAMES
TTYSBDC1ATTRIBUTES
RxCUI16669561CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01FAAnticholinergicsATC1-4atropine
ATCV03ABAntidotesATC1-4atropine / pralidoxime
ATCV03ABAntidotesATC1-4pralidoxime
ATCA03BABelladonna alkaloids, tertiary aminesATC1-4atropine
FDASPLN0000175574AnticholinergicEPChas_epcatropine
FDASPLN0000175700Cholinergic Muscarinic AntagonistEPChas_epcatropine
FDASPLN0000175742Cholinesterase ReactivatorEPChas_epcpralidoxime
FDASPLN0000175370Cholinergic AntagonistsMOAhas_moaatropine
FDASPLN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moaatropine
FDASPLN0000000080Cholinesterase ReactivatorsMOAhas_moapralidoxime
MEDRTD001285AtropineCHEMhas_ingredientatropine
MEDRTD011220Pralidoxime CompoundsCHEMhas_ingredientpralidoxime
MEDRTD011220Pralidoxime CompoundsCHEMhas_ingredientpralidoxime chloride
MEDRTD001249AsthmaDISEASEci_withatropine
MEDRTD001919BradycardiaDISEASEmay_treatatropine
MEDRTD003093Colitis, UlcerativeDISEASEci_withatropine
MEDRTD004342Drug HypersensitivityDISEASEci_withpralidoxime
MEDRTD004342Drug HypersensitivityDISEASEci_withpralidoxime chloride
MEDRTD004342Drug HypersensitivityDISEASEci_withatropine
MEDRTD062787Drug OverdoseDISEASEmay_treatpralidoxime chloride
MEDRTD062787Drug OverdoseDISEASEmay_treatpralidoxime
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatatropine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_preventpralidoxime chloride
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatpralidoxime chloride
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_preventpralidoxime
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatpralidoxime
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withatropine
MEDRTD006323Heart ArrestDISEASEmay_treatatropine
MEDRTD006327Heart BlockDISEASEci_withatropine
MEDRTD007415Intestinal ObstructionDISEASEci_withatropine
MEDRTD007499Iris DiseasesDISEASEci_withatropine
MEDRTD007674Kidney DiseasesDISEASEci_withatropine
MEDRTD007905Lens DiseasesDISEASEci_withatropine
MEDRTD008107Liver DiseasesDISEASEci_withatropine
MEDRTD008532Megacolon, ToxicDISEASEci_withatropine
MEDRTD009157Myasthenia GravisDISEASEci_withatropine
MEDRTD015878MydriasisDISEASEinducesatropine
MEDRTD011041PoisoningDISEASEmay_treatpralidoxime chloride
MEDRTD011041PoisoningDISEASEmay_treatpralidoxime
MEDRTD011041PoisoningDISEASEci_withpralidoxime chloride
MEDRTD011041PoisoningDISEASEci_withpralidoxime
MEDRTD011041PoisoningDISEASEmay_treatatropine
MEDRTD012848Sinoatrial BlockDISEASEmay_treatatropine
MEDRTD013276Stomach UlcerDISEASEmay_treatatropine
MEDRTD013610TachycardiaDISEASEci_withatropine
MEDRTD013971ThyrotoxicosisDISEASEci_withatropine
MEDRTD000267Tissue AdhesionsDISEASEci_withatropine
MEDRTD014517Ureteral ObstructionDISEASEci_withatropine
MEDRTD014605UveitisDISEASEmay_treatatropine
MEDRTD014987XerostomiaDISEASEinducesatropine
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moaatropine
MEDRTN0000000080Cholinesterase ReactivatorsMOAhas_moapralidoxime chloride
MEDRTN0000000080Cholinesterase ReactivatorsMOAhas_moapralidoxime
MEDRTN0000008383Decreased Acetylcholine ActivityPEhas_pepralidoxime chloride
MEDRTN0000008383Decreased Acetylcholine ActivityPEhas_pepralidoxime
MEDRTN0000008779Decreased Parasympathetic Acetylcholine ActivityPEhas_peatropine
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_peatropine
MEDRTN0000009808Positive ChronotropyPEhas_peatropine
MEDRTN0000009820Pupillary DilationPEhas_peatropine
MEDRTN0000009842Salivation InhibitionPEhas_peatropine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_HUMAN_DRUGUS